This session at GWC 2026 highlights innovations in drug therapies for conditions like endometriosis, fibroids, menopause, and infertility. It includes discussions on hormone therapies, personalized medicine, clinical trials, and regulatory pathways. Perinatologists, obstetric nurses, and consultants of high-risk pregnancies depend on the Obstetrics Congress to be updated with the protocols that actually save lives. Pharmacologists, clinical researchers, gynecologists, and industry scientists will collaborate to translate laboratory findings into impactful therapies.